The Silicon Review
The Silicon Review – May 15, 2017 Evoke Neuroscience named as one of 50 most valuable brands of the year 2017. Read the Full Article
The Silicon Review
The Silicon Review – January 30, 2017 Dr. David Hagedorn discusses Evoke Neuroscience mission, company structure and future plans. Read the Full Article
New Year, New You: Get moving for your body and your brain!
With the start of 2017, chances are you’ve made some New Year’s Resolutions. If you did, we are willing to bet that living a healthier lifestyle – things like losing…
TransTech
TransTech – September 27, 2016 Evoke Neuroscience Recognized as Key Innovator in Advancing Transformative Technology for Mental Wellbeing Read the Full Article
PR.com
PR.com – August 18, 2016 Medical Brain Tech Company Evoke Neuroscience Ranked by Inc. 500 as One of America’s Fastest Growing Companies Read the Full Article
Patch.com
Patch.com – August 17, 2016 Evoke Neuroscience was named the seventh-fastest growing company in the five New York City boroughs by Inc. Magazine. Read the Full Article
Inc.com
Inc.com – August 17, 2016 Evoke Neuroscience Ranked by Inc. 500 as One of America’s Fastest Growing Companies. Read the Full Article
Medical Economics
Medical Economics eBook – June 27, 2016 Getting patients on-board with their own treatment goals and disease management is essential, especially now as physicians prepare for an era of quality-based payments….
Neuroscience & Neurology: Looking Inside Our Heads – Brain Imaging and Patient Adherence
BrainBlogger.com – June 16, 2016 Studies show that helping patients to visualize the nature of their healthcare issues is a critical step in achieving acceptance of a diagnosis, and therefore adherence…
University of Western Ontario Researchers Investigate Effects of Sub-Concussive and Concussive Head Impacts in Youth Soccer using Evoke Neuroscience and GForceTracker Technologies
CBC Radio – May 19, 2016 Dr. James Thompson, Ph.D. co-founder of Evoke Neuroscience shares how a new sports concussion study beginning in May 2016 will measure the effects of sub-concussive…
The eVox system is a Class II medical device that has received Section 510(K) clearance from the FDA. It is intended for the acquisition, display, and storage, of electrical activity of a patient’s brain including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.